Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Structure-Activity Relationships of the Sustained Effects of Adenosine A2A Receptor Agonists Driven by Slow Dissociation Kinetics.
Hothersall JD, Guo D, Sarda S, Sheppard RJ, Chen H, Keur W, Waring MJ, IJzerman AP, Hill SJ, Dale IL, Rawlins PB. Hothersall JD, et al. Among authors: Dale IL. Mol Pharmacol. 2017 Jan;91(1):25-38. doi: 10.1124/mol.116.105551. Epub 2016 Nov 1. Mol Pharmacol. 2017. PMID: 27803241 Free PMC article.
Sustained wash-resistant receptor activation responses of GPR119 agonists.
Hothersall JD, Bussey CE, Brown AJ, Scott JS, Dale I, Rawlins P. Hothersall JD, et al. Eur J Pharmacol. 2015 Sep 5;762:430-42. doi: 10.1016/j.ejphar.2015.06.031. Epub 2015 Jun 20. Eur J Pharmacol. 2015. PMID: 26101059
AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.
Rhyasen GW, Hattersley MM, Yao Y, Dulak A, Wang W, Petteruti P, Dale IL, Boiko S, Cheung T, Zhang J, Wen S, Castriotta L, Lawson D, Collins M, Bao L, Ahdesmaki MJ, Walker G, O'Connor G, Yeh TC, Rabow AA, Dry JR, Reimer C, Lyne P, Mills GB, Fawell SE, Waring MJ, Zinda M, Clark E, Chen H. Rhyasen GW, et al. Among authors: Dale IL. Mol Cancer Ther. 2016 Nov;15(11):2563-2574. doi: 10.1158/1535-7163.MCT-16-0141. Epub 2016 Aug 29. Mol Cancer Ther. 2016. PMID: 27573426 Free article.
Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP1.
Shaw J, Dale I, Hemsley P, Leach L, Dekki N, Orme JP, Talbot V, Narvaez AJ, Bista M, Martinez Molina D, Dabrowski M, Main MJ, Gianni D. Shaw J, et al. Among authors: Dale I. SLAS Discov. 2019 Feb;24(2):121-132. doi: 10.1177/2472555218813332. Epub 2018 Dec 13. SLAS Discov. 2019. PMID: 30543471 Free PMC article.
Potent and selective bivalent inhibitors of BET bromodomains.
Waring MJ, Chen H, Rabow AA, Walker G, Bobby R, Boiko S, Bradbury RH, Callis R, Clark E, Dale I, Daniels DL, Dulak A, Flavell L, Holdgate G, Jowitt TA, Kikhney A, McAlister M, Méndez J, Ogg D, Patel J, Petteruti P, Robb GR, Robers MB, Saif S, Stratton N, Svergun DI, Wang W, Whittaker D, Wilson DM, Yao Y. Waring MJ, et al. Among authors: Dale I. Nat Chem Biol. 2016 Dec;12(12):1097-1104. doi: 10.1038/nchembio.2210. Epub 2016 Oct 24. Nat Chem Biol. 2016. PMID: 27775716
A Comparative Study of Fluorescence Assays in Screening for BRD4.
Hansson P, Boyd H, Dale IL, Dahl G, Nicolaus F, Bowen W, Doering K, Dunsmore C, Cotton G, Lindmark H. Hansson P, et al. Among authors: Dale IL. Assay Drug Dev Technol. 2018 Oct;16(7):372-383. doi: 10.1089/adt.2018.850. Epub 2018 Oct 9. Assay Drug Dev Technol. 2018. PMID: 30307314
75 results
Jump to page